Faron Pharmaceuticals Market & Company News

12.07.2019 07:53 Faron Pharmaceuticals Faron Pharmaceuticals says clinical study on cancer treatment shows 'potential early efficacy' SMW
12.07.2019 07:00 Faron Pharma. Oy MATINS study update RNS
05.07.2019 09:00 Faron Pharma. Oy Price Monitoring Extension RNS
04.07.2019 16:40 Faron Pharma. Oy Second Price Monitoring Extn RNS
04.07.2019 16:35 Faron Pharma. Oy Price Monitoring Extension RNS
04.07.2019 14:00 Faron Pharma. Oy Price Monitoring Extension RNS
04.07.2019 09:31 Faron Pharma. Oy Holdings in Company RNS
01.07.2019 12:10 Faron Pharma. Oy Grant of options RNS
26.06.2019 08:46 Faron Pharmaceuticals Faron Pharmaceuticals to continue study on acute respiratory distress syndrome SMW
26.06.2019 07:00 Faron Pharma. Oy Phase II INFORAAA study update RNS
14.06.2019 08:24 Faron Pharmaceuticals Faron Pharmaceuticals Oy says final study sheds light on interferon-beta drug setback SMW
14.06.2019 07:00 Faron Pharma. Oy Final results from YODA study RNS
28.05.2019 12:27 Faron Pharma. Oy Results of AGM RNS
24.05.2019 09:32 Faron Pharma. Oy AGM update, Board & management changes RNS
22.05.2019 12:51 Faron Pharma. Oy Grant of Options RNS
21.05.2019 09:21 Faron Pharma. Oy Holding(s) in Company RNS
16.05.2019 09:16 Faron Pharma. Oy Holding(s) in Company RNS
14.05.2019 07:01 Faron Pharma. Oy Holdings in Company RNS
14.05.2019 07:00 Faron Pharma. Oy Share Subscription and Issue of Equity RNS
07.05.2019 07:05 Faron Pharma. Oy Notice of AGM RNS
07.05.2019 07:00 Faron Pharma. Oy Final Results for the year ended 31 December 2018 RNS
02.05.2019 17:20 Faron Pharma. Oy Statement regarding Price Movement RNS
02.05.2019 14:05 Faron Pharma. Oy Second Price Monitoring Extn RNS
02.05.2019 14:00 Faron Pharma. Oy Price Monitoring Extension RNS
29.04.2019 09:24 Faron Pharmaceuticals Faron Pharmaceuticals says treatment for respiratory distress syndrome shows no improvement versus placebo SMW
29.04.2019 07:00 Faron Pharma. Oy Results from the Japanese Phase III study RNS
25.04.2019 16:09 Faron Pharma. Oy Holding(s) in Company RNS
12.04.2019 13:20 Faron Pharma. Oy Holding(s) in Company RNS
11.04.2019 07:00 Faron Pharma. Oy First expansion cohort for MATINS trial part 2 RNS
10.04.2019 11:41 Faron Pharma. Oy Holding(s) in Company RNS
05.04.2019 07:00 Faron Pharma. Oy Notice of Results RNS
02.04.2019 09:23 Faron Pharma. Oy Holdings in Company RNS
29.03.2019 07:00 Faron Pharma. Oy Holding(s) in Company RNS
28.03.2019 12:54 Faron Pharma. Oy Results of the Placing and Subscription RNS
26.03.2019 15:31 Faron Pharma. Oy Result of Placing and Issue Price RNS
26.03.2019 07:00 Faron Pharma. Oy Proposed Placing to raise approximately EUR 3m RNS
21.02.2019 10:25 Faron Pharmaceuticals Faron Pharmaceuticals says early observations from Clevegen trial 'encouraging' SMW
21.02.2019 07:00 Faron Pharma. Oy MATINS study update RNS
13.02.2019 08:57 Faron Pharma. Oy New data published by Clinical Cancer Research RNS
19.12.2018 07:00 Faron Pharma. Oy Traumakine update - YODA results RNS
14.12.2018 11:20 Faron Pharma. Oy First patient dosed in phase I/II MATINS study RNS
11.12.2018 16:26 Faron Pharma. Oy Holding(s) in Company RNS
05.12.2018 10:27 Faron Pharmaceuticals Faron Pharmaceuticals says trial shows ARDS treatment 'potentially very effective' SMW
05.12.2018 07:00 Faron Pharma. Oy Patient subgroup identified from INTEREST trial RNS
03.12.2018 08:49 Faron Pharmaceuticals Faron Pharmaceuticals' cancer treatment gets regulatory nod for clinical trail SMW
03.12.2018 07:00 Faron Pharma. Oy Faron receives CTA approval for Clevegen RNS
06.11.2018 15:52 Faron Pharma. Oy PDMR Dealings RNS
23.10.2018 11:05 Faron Pharma. Oy Second Price Monitoring Extn RNS
23.10.2018 11:00 Faron Pharma. Oy Price Monitoring Extension RNS
23.10.2018 09:06 Faron Pharma. Oy Second Price Monitoring Extn RNS
Showing 1 to 50 of 266